Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

A Protein E-PilA Fusion Protein Shows Vaccine Potential against Nontypeable Haemophilus influenzae in Mice and Chinchillas.

Ysebaert C, Denoël P, Weynants V, Bakaletz LO, Novotny LA, Godfroid F, Hermand P.

Infect Immun. 2019 Jul 23;87(8). pii: e00345-19. doi: 10.1128/IAI.00345-19. Print 2019 Aug.

2.

Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.

Moens L, Hermand P, Wellens T, Wuyts G, Derua R, Waelkens E, Ysebaert C, Godfroid F, Bossuyt X.

Hum Vaccin Immunother. 2018 May 4;14(5):1234-1242. doi: 10.1080/21645515.2018.1430541. Epub 2018 Feb 21.

3.

Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen.

Hermand P, Vandercammen A, Mertens E, Di Paolo E, Verlant V, Denoël P, Godfroid F.

Hum Vaccin Immunother. 2017 Jan 2;13(1):220-228. doi: 10.1080/21645515.2016.1234553. Epub 2016 Oct 21.

4.

Interleukin-22 protects against non-typeable Haemophilus influenzae infection: alteration during chronic obstructive pulmonary disease.

Sharan R, Perez-Cruz M, Kervoaze G, Gosset P, Weynants V, Godfroid F, Hermand P, Trottein F, Pichavant M, Gosset P.

Mucosal Immunol. 2017 Jan;10(1):139-149. doi: 10.1038/mi.2016.40. Epub 2016 May 4.

PMID:
27143304
5.

Role of Pht proteins in attachment of Streptococcus pneumoniae to respiratory epithelial cells.

Kallio A, Sepponen K, Hermand P, Denoël P, Godfroid F, Melin M.

Infect Immun. 2014 Apr;82(4):1683-91. doi: 10.1128/IAI.00699-13. Epub 2014 Feb 3.

6.

Panel 6: Vaccines.

Pelton SI, Pettigrew MM, Barenkamp SJ, Godfroid F, Grijalva CG, Leach A, Patel J, Murphy TF, Selak S, Bakaletz LO.

Otolaryngol Head Neck Surg. 2013 Apr;148(4 Suppl):E90-101. doi: 10.1177/0194599812466535. Review.

7.

Induction of Bordetella pertussis-specific immune memory by DTPa vaccines.

Morel S, Denoël P, Godfroid F, Cortvrindt C, Vanderheyde N, Poolman J.

Vaccine. 2011 Apr 18;29(18):3449-55. doi: 10.1016/j.vaccine.2011.02.062. Epub 2011 Mar 5.

PMID:
21382483
8.

Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharides.

Denoël P, Godfroid F, Hermand P, Verlant V, Poolman J.

Vaccine. 2011 Sep 2;29(38):6451-3. doi: 10.1016/j.vaccine.2011.01.085. Epub 2011 Feb 11.

PMID:
21315695
9.

Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens.

Godfroid F, Hermand P, Verlant V, Denoël P, Poolman JT.

Infect Immun. 2011 Jan;79(1):238-45. doi: 10.1128/IAI.00378-10. Epub 2010 Oct 18.

10.
11.

Are vaccination programs and isolate polymorphism linked to pertussis re-emergence?

Godfroid F, Denoël P, Poolman J.

Expert Rev Vaccines. 2005 Oct;4(5):757-78. Review.

PMID:
16221076
12.

Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model.

Denoël P, Godfroid F, Guiso N, Hallander H, Poolman J.

Vaccine. 2005 Nov 16;23(46-47):5333-41. Epub 2005 Jul 11.

PMID:
16054273
13.

Diphtheria-tetanus-pertussis (DTP) combination vaccines and evaluation of pertussis immune responses.

Godfroid F, Denoël P, de Grave D, Schuerman L, Poolman J.

Int J Med Microbiol. 2004 Oct;294(5):269-76. Review.

PMID:
15532986
14.

Genetic organisation of the lipopolysaccharide O-antigen biosynthesis region of brucella melitensis 16M (wbk).

Godfroid F, Cloeckaert A, Taminiau B, Danese I, Tibor A, de Bolle X, Mertens P, Letesson JJ.

Res Microbiol. 2000 Oct;151(8):655-68.

PMID:
11081580
15.

Conservation of seven genes involved in the biosynthesis of the lipopolysaccharide O-side chain in Brucella spp.

Cloeckaert A, Grayon M, Verger JM, Letesson JJ, Godfroid F.

Res Microbiol. 2000 Apr;151(3):209-16.

PMID:
10865948
16.

Antigenic properties of peptidic mimics for epitopes of the lipopolysaccharide from Brucella.

De Bolle X, Laurent T, Tibor A, Godfroid F, Weynants V, Letesson JJ, Mertens P.

J Mol Biol. 1999 Nov 19;294(1):181-91.

PMID:
10556037
17.

Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages.

Godfroid F, Taminiau B, Danese I, Denoel P, Tibor A, Weynants V, Cloeckaert A, Godfroid J, Letesson JJ.

Infect Immun. 1998 Nov;66(11):5485-93.

18.

Survival of a bacterioferritin deletion mutant of Brucella melitensis 16M in human monocyte-derived macrophages.

Denoel PA, Crawford RM, Zygmunt MS, Tibor A, Weynants VE, Godfroid F, Hoover DL, Letesson JJ.

Infect Immun. 1997 Oct;65(10):4337-40.

19.

Characterization of smooth lipopolysaccharides and O polysaccharides of Brucella species by competition binding assays with monoclonal antibodies.

Weynants V, Gilson D, Cloeckaert A, Tibor A, Denoel PA, Godfroid F, Limet JN, Letesson JJ.

Infect Immun. 1997 May;65(5):1939-43.

Supplemental Content

Loading ...
Support Center